Valter Freiro Torres Russo

Title: Valter Freiro Torres Russo: Innovator in Pharmaceutical Chemistry

Introduction

Valter Freiro Torres Russo is a notable inventor based in Sao Paulo, Brazil. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the area of enantiomeric compounds. His work focuses on the manipulation of enantiomers to enhance the efficacy and safety of pharmaceutical compositions.

Latest Patents

Valter Freiro Torres Russo holds a patent for "Non-racemic mixtures of (S) and (R) enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; related processes and pharmaceutical compositions." This invention describes a method for separating the enantiomers of N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide. The patent outlines the enantiomeric manipulation of these compounds to achieve various enantiomeric excesses of (S)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide. This manipulation is crucial for quantifying the effects of (R)-N-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide on anesthetic and cardiotoxic properties. The resulting compounds demonstrate significant improvements in anesthetic properties while maintaining a cardiotoxic profile equivalent to the pure enantiomer.

Career Highlights

Valter Freiro Torres Russo is associated with Cristalia Produtos Quimicos Farmaceuticos Ltda., where he applies his expertise in pharmaceutical chemistry. His innovative approach to enantiomeric compounds has positioned him as a key figure in the development of safer and more effective pharmaceutical products.

Collaborations

Valter has collaborated with notable colleagues, including Elisa Mannochio De Souza Russo and Ogari De Castro Pacheco. These collaborations have further enhanced the research and development efforts in the field of pharmaceutical chemistry.

Conclusion

Valter Freiro Torres Russo's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight the importance of enantiomeric manipulation in drug development. His work continues to influence the field and improve patient outcomes through enhanced pharmaceutical compositions.